標(biāo)題: Titlebook: Chronic Kidney Disease and Hypertension; Matthew R. Weir,Edgar V. Lerma Book 2015 Springer Science+Business Media New York 2015 BP Monitor [打印本頁] 作者: 贊美 時間: 2025-3-21 17:39
書目名稱Chronic Kidney Disease and Hypertension影響因子(影響力)
書目名稱Chronic Kidney Disease and Hypertension影響因子(影響力)學(xué)科排名
書目名稱Chronic Kidney Disease and Hypertension網(wǎng)絡(luò)公開度
書目名稱Chronic Kidney Disease and Hypertension網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Chronic Kidney Disease and Hypertension被引頻次
書目名稱Chronic Kidney Disease and Hypertension被引頻次學(xué)科排名
書目名稱Chronic Kidney Disease and Hypertension年度引用
書目名稱Chronic Kidney Disease and Hypertension年度引用學(xué)科排名
書目名稱Chronic Kidney Disease and Hypertension讀者反饋
書目名稱Chronic Kidney Disease and Hypertension讀者反饋學(xué)科排名
作者: affluent 時間: 2025-3-21 22:26
978-1-4939-4704-1Springer Science+Business Media New York 2015作者: cyanosis 時間: 2025-3-22 02:35 作者: eucalyptus 時間: 2025-3-22 07:12
Clinical Hypertension and Vascular Diseaseshttp://image.papertrans.cn/c/image/226386.jpg作者: Eviction 時間: 2025-3-22 12:05 作者: 輕信 時間: 2025-3-22 13:46 作者: 輕信 時間: 2025-3-22 20:13
https://doi.org/10.1007/978-3-319-21103-9e is steadily escalating to hazardous proportions due to the increasing incidence of hypertension, diabetes, metabolic syndrome, and other risk factors. Hypertension can be a cause or consequence of CKD. Nevertheless, the coexistence of hypertension and CKD portends poor prognosis due to the occurre作者: Excitotoxin 時間: 2025-3-22 21:17
Story Credibility in Narrative Argumentsute to hypertension in these patients, including volume expansion and activation of the renin–angiotensin–aldosterone system. This chapter deals with the role of the sympathetic nervous system in hypertension and CKD progression in these patients and with the mechanisms that can contribute to the ac作者: nitroglycerin 時間: 2025-3-23 02:37
https://doi.org/10.1007/978-1-349-06892-0 models and new options to block the renin–angiotensin–aldosterone axis such as renin inhibitors, angiotensin II type 2 receptor agonists, angiotensin vaccines and aldosterone synthase inhibitors are under scrutiny with variable results so far. Interventions in different hormones and autacoids, enzy作者: 凝乳 時間: 2025-3-23 08:46
Key Currencies and Financial Centresor blocker (ARB) or a direct renin inhibitor (DRI) similarly reduces blood pressure (BP) when each is used as monotherapy in patients with hypertension. Both ACE inhibitors and ARBs also slow down the progressive decline in renal function, which marks renal injury, particularly in patients with diab作者: 巫婆 時間: 2025-3-23 12:09
Reflections on a Troubled World Economyhe availability of proven therapeutic approaches including lifestyle modification and the use of antihypertensive drugs, control rates for hypertension remain unsatisfactory across the globe. While the majority of patients can be controlled with adequate combination therapy of drugs with different m作者: 淺灘 時間: 2025-3-23 15:55
Key Currencies and Financial Centresll or is reduced insufficiently during treatment. Treatment resistance, therefore, is one of the challenges of contemporary hypertension research. Since the autonomic system plays a major role in the pathogenesis of hypertension, in particular when this is resistant to drug treatment, investigators 作者: 高調(diào) 時間: 2025-3-23 21:04
Key Currencies and Financial Centresoviders. The idea of a vaccine for hypertension that could ameliorate or cure the disease with a single procedure is innately appealing. The discovery that renin increased blood pressure raised the possibility that renin could be the key to the etiology of hypertension. Administering renin from one 作者: 必死 時間: 2025-3-23 23:11
https://doi.org/10.1007/978-1-349-06892-0, white-coat hypertension, while also being well described, is generally accepted as exhibiting greater risk than normotension. More recently, the identification of masked hypertension (reverse white-coat hypertension using older terminology) has added to the complexity of the hypertensive phenotype作者: Mucosa 時間: 2025-3-24 05:07 作者: analogous 時間: 2025-3-24 08:37
No More Business as Usual: Viet Nam, The etiology of primary (essential) hypertension is complex, and consists of genetic, maternal–fetal, and environmental factors. Ideally, one would like to identify modifiable risk factors that could either prevent or treat hypertension. An elevated serum uric acid, which is a clearly amendable ris作者: ingrate 時間: 2025-3-24 13:01
You Must Be Mad: UN Headquarters,the pathogenesis of preeclampsia (PE) have yet to be fully elucidated. PE affects the vasculature of many target maternal organs including the kidney, liver, and brain. Growing evidence supports the concept that the placenta plays a central role in the pathogenesis of PE and that reduced uteroplacen作者: 過濾 時間: 2025-3-24 16:46 作者: APEX 時間: 2025-3-24 20:45
https://doi.org/10.1007/978-3-030-77063-1ed a significant heritable component to the most common form, essential hypertension. Several strategies have been developed to identify a genetic variation that is associated with hypertension. Genome-wide association studies (GWAS) were developed to identify particular genetic markers (single-nucl作者: 詳細(xì)目錄 時間: 2025-3-25 00:06
,Surviving in the People’s Paradise: DPRK,tors. These conditions include primary aldosteronism and some forms of congenital adrenal hyperplasia, Cushing’s, and pheochromocytoma/paraganglioma syndromes, respectively. One needs to remember that these conditions are rare, but associate with significant morbidity and need to be included in the 作者: 妨礙 時間: 2025-3-25 04:41 作者: 廢止 時間: 2025-3-25 08:18
https://doi.org/10.1007/978-3-030-77063-1essed during time in an attempt to decrease the mortality of renal patients; left ventricular hypertrophy, anemia, mineral metabolism disturbance, inflammation, endothelial dysfunction are among them. However, in 2013 we still have an enormous mortality rate. In this context, we tried to define newe作者: gerontocracy 時間: 2025-3-25 14:59
Book 2015sease and Hypertension. is a current, concise, and practical guide to the identification, treatment and management of hypertension in patients with chronic kidney disease. In depth chapters discuss many relevant clinical questions and the future of treatment through medications and or novel new devi作者: ULCER 時間: 2025-3-25 18:41
Book 2015ronic kidney disease. In depth chapters discuss many relevant clinical questions and the future of treatment through medications and or novel new devices..Written by expert authors, .Chronic Kidney Disease and Hypertension. provides an up-to-date perspective on management and treatment and how it may re-shape practice approaches tomorrow..作者: CURB 時間: 2025-3-25 22:06
Story Credibility in Narrative Argumentstivation of the sympathetic nervous system, including angiotensin II, increased oxidative stress, and renalase. Finally, this chapter reviews the current role of renal denervation in the management of hypertension in these patients.作者: 失望未來 時間: 2025-3-26 00:16
expert authors, .Chronic Kidney Disease and Hypertension. provides an up-to-date perspective on management and treatment and how it may re-shape practice approaches tomorrow..978-1-4939-4704-1978-1-4939-1982-6作者: 吃掉 時間: 2025-3-26 08:21 作者: neurologist 時間: 2025-3-26 10:41
No More Business as Usual: Viet Nam,ed serum uric acid to the presence of renal insufficiency, obesity, and metabolic syndrome. In this chapter, we discuss the evidence that supports the role of uric acid in hypertension as well as current challenges of this hypothesis.作者: neutralize 時間: 2025-3-26 16:26 作者: 傀儡 時間: 2025-3-26 18:29 作者: 愛社交 時間: 2025-3-27 00:54
Identifying the Warrant of an Argumenttended to be updated every 4–5 years as data became available that would further solidify or change practice patterns. JNC 8 was published 10 years after JNC 7, so a departure from previous guidelines.作者: homeostasis 時間: 2025-3-27 03:01
https://doi.org/10.1007/978-3-319-21103-9ents with CKD. Aggressive therapeutic strategies should be applied to prevent the onset and progression of hypertension in patients with CKD. Ultimately, it is the blood pressure level which determines the prognosis of patients afflicted with CKD.作者: fodlder 時間: 2025-3-27 08:05 作者: 客觀 時間: 2025-3-27 12:25
Key Currencies and Financial Centresnd ARB therapy also decrease the high cardiovascular (CV) event rate common to high-risk cardiac patients. Moreover, ACE inhibitors and ARBs are both of proven benefit in forms of heart failure (HF) characterized by a reduced ejection fraction (EF).作者: 廢除 時間: 2025-3-27 16:55 作者: 招募 時間: 2025-3-27 20:36 作者: grieve 時間: 2025-3-27 22:49 作者: Resection 時間: 2025-3-28 02:17 作者: 不成比例 時間: 2025-3-28 06:40 作者: 厭食癥 時間: 2025-3-28 12:01
You Must Be Mad: UN Headquarters,on should be aggressively treated, the optimal target for blood pressure control in children with CKD has not been clearly defined. In most cases, pharmacologic treatment should be initiated with a drug that inhibits the renin–angiotensin–aldosterone system and individualized to the patient.作者: 鎮(zhèn)痛劑 時間: 2025-3-28 15:07
Hypertension in Children with Chronic Kidney Disease,on should be aggressively treated, the optimal target for blood pressure control in children with CKD has not been clearly defined. In most cases, pharmacologic treatment should be initiated with a drug that inhibits the renin–angiotensin–aldosterone system and individualized to the patient.作者: 挑剔為人 時間: 2025-3-28 19:39 作者: POINT 時間: 2025-3-29 00:57
Changes in Guideline Trends and Applications in Practice: JNC 2013 and the Future,e than three decades with the first report published in 1977. The purpose of this report is to provide an authoritative review and summary of available data from clinical trials that will educate and update healthcare providers on approaches to treatment and cardiovascular risk reduction of appropri作者: 拾落穗 時間: 2025-3-29 05:04 作者: 動脈 時間: 2025-3-29 10:45
Resistant Hypertension in Patients with Chronic Kidney Disease,e is steadily escalating to hazardous proportions due to the increasing incidence of hypertension, diabetes, metabolic syndrome, and other risk factors. Hypertension can be a cause or consequence of CKD. Nevertheless, the coexistence of hypertension and CKD portends poor prognosis due to the occurre作者: Carcinogenesis 時間: 2025-3-29 13:56
Neurogenic Factors in Hypertension Associated With Chronic Kidney Disease,ute to hypertension in these patients, including volume expansion and activation of the renin–angiotensin–aldosterone system. This chapter deals with the role of the sympathetic nervous system in hypertension and CKD progression in these patients and with the mechanisms that can contribute to the ac作者: capillaries 時間: 2025-3-29 19:09 作者: FOIL 時間: 2025-3-29 21:37 作者: 大包裹 時間: 2025-3-30 00:31
Renal Sympathetic Denervation,he availability of proven therapeutic approaches including lifestyle modification and the use of antihypertensive drugs, control rates for hypertension remain unsatisfactory across the globe. While the majority of patients can be controlled with adequate combination therapy of drugs with different m作者: LUMEN 時間: 2025-3-30 04:09
Novel Baroreceptor Activation Therapy,ll or is reduced insufficiently during treatment. Treatment resistance, therefore, is one of the challenges of contemporary hypertension research. Since the autonomic system plays a major role in the pathogenesis of hypertension, in particular when this is resistant to drug treatment, investigators 作者: FLAG 時間: 2025-3-30 11:07
Blood Pressure Vaccines,oviders. The idea of a vaccine for hypertension that could ameliorate or cure the disease with a single procedure is innately appealing. The discovery that renin increased blood pressure raised the possibility that renin could be the key to the etiology of hypertension. Administering renin from one 作者: 走調(diào) 時間: 2025-3-30 13:24
Masked Hypertension: Does It Lead to CVD or CKD?,, white-coat hypertension, while also being well described, is generally accepted as exhibiting greater risk than normotension. More recently, the identification of masked hypertension (reverse white-coat hypertension using older terminology) has added to the complexity of the hypertensive phenotype作者: 一起 時間: 2025-3-30 16:45 作者: lacrimal-gland 時間: 2025-3-30 21:45
Uric Acid and Hypertension: Is There Really a Link?, The etiology of primary (essential) hypertension is complex, and consists of genetic, maternal–fetal, and environmental factors. Ideally, one would like to identify modifiable risk factors that could either prevent or treat hypertension. An elevated serum uric acid, which is a clearly amendable ris作者: 草率女 時間: 2025-3-31 03:25
Preeclampsia: Angiogenic Factors, Blood Pressure, and the Kidney,the pathogenesis of preeclampsia (PE) have yet to be fully elucidated. PE affects the vasculature of many target maternal organs including the kidney, liver, and brain. Growing evidence supports the concept that the placenta plays a central role in the pathogenesis of PE and that reduced uteroplacen作者: agnostic 時間: 2025-3-31 07:21
Inflammation and Hypertension, a condition of low-grade systemic inflammation is frequently documented in hypertensive subjects and data from animal models of hypertension demonstrated that inflammatory events are commonly seen within the target organs of hypertensive damage (such as kidneys, arteries, and the brain). Whether th作者: Decline 時間: 2025-3-31 13:11
Genome-Wide Association Studies (Gwas) of Blood Pressure in Different Populations,ed a significant heritable component to the most common form, essential hypertension. Several strategies have been developed to identify a genetic variation that is associated with hypertension. Genome-wide association studies (GWAS) were developed to identify particular genetic markers (single-nucl作者: Decimate 時間: 2025-3-31 15:12
Endocrine Hypertension and Chronic Kidney Disease,tors. These conditions include primary aldosteronism and some forms of congenital adrenal hyperplasia, Cushing’s, and pheochromocytoma/paraganglioma syndromes, respectively. One needs to remember that these conditions are rare, but associate with significant morbidity and need to be included in the 作者: Tailor 時間: 2025-3-31 18:57
Hypertension in Children with Chronic Kidney Disease,eft ventricular hypertrophy, increased carotid intimal thickness, and some subtle neurocognitive defects. Although widely acknowledged that hypertension should be aggressively treated, the optimal target for blood pressure control in children with CKD has not been clearly defined. In most cases, pha作者: Consensus 時間: 2025-4-1 01:10 作者: 胡言亂語 時間: 2025-4-1 02:28 作者: ALERT 時間: 2025-4-1 06:32
